The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D02 | Emollients and protectives | |
| 3 | D02B | Protectives against UV-radiation | |
| 4 | D02BB | Protectives against UV-radiation for systemic use |
| Code | Title | |
|---|---|---|
| D02BB01 | Betacarotene | |
| D02BB02 |
| Active Ingredient | Description | |
|---|---|---|
| Afamelanotide |
Afamelanotide is a synthetic tridecapeptide and a structural analogue of α-melanocyte stimulating hormone (α-MSH). Afamelanotide is a melanocortin receptor agonist and binds predominantly to the melanocortin-1 receptor (MC1R). Afamelanotide is thought to mimic the endogenous compound’s pharmacological activity by activating the synthesis of eumelanin mediated by the MC1R receptor. Eumelanin contributes to photoprotection through different mechanisms. |
|
| beta-Carotene |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| SCENESSE Implant | European Medicines Agency (EU) | MPI, EU: SmPC |
